Form4insider filings, from the source

SEC Form 4 · accession 0001140361-16-082621

OncoMed Pharmaceuticals Inc · OMED

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Oct 10, 2016
Accepted (ET)
Oct 12, 2016 · 8:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001302573

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2Oct 10, 2016J3,287$0.00D1,425,027ISee Footnote
Common StockF3Oct 10, 2016J822$0.00D489,109ISee Footnote
Common Stockholding———77,087D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses